{
    "nctId": "NCT00111241",
    "briefTitle": "Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors",
    "officialTitle": "Assessment of Knee Joint Articular Cartilage Volume Change, Bone Loss and Change in Body Composition in Women Treated With Anastrozole or Letrozole and Comparison With Untreated Controls",
    "overallStatus": "COMPLETED",
    "conditions": "Arthralgia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 115,
    "primaryOutcomeMeasure": "Knee Cartilage Volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\nGroup 1 :\n\n* Aged 40 - 65\n* Non-hysterectomised women who have undergone breast surgery\n* Women on aromatase inhibitors within preceding 12 weeks\n\nGroup 2 : control group\n\n* Healthy, non-hysterectomised women aged 40-65 .\n\nExclusion Criteria:\n\n* Previous knee injury requiring non-weight bearing treatment for \\> 24 hrs or surgery (including arthroscopy)\n* Inability to complete the study (eg proposed relocation)\n* Contraindication to undergoing an MRI including pacemaker, metal sutures, presence of shrapnel, iron filings in eye\n* Claustrophobia\n\nAdditional Exclusions for Group 1\n\n* Treatment with tamoxifen for \\> 8 weeks prior to commencement\n* Knee pain lasting for \\>24 hours in the last 5 years (prior to commencement on anastrozole or letrozole)\n* Anastrazole or Letrozole therapy for \\> 12 weeks",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}